These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 6158811)

  • 1. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of human serum bactericidal activity by specific IgM antibodies of normal and anti-O immune rabbit sera against pseudo-serum-resistant strains of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol A; 1980 Feb; 246(1):50-66. PubMed ID: 6999780
    [No Abstract]   [Full Text] [Related]  

  • 4. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonization requirements of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):92-103. PubMed ID: 7032156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards serodiagnosis of Serratia marcescens infections: examination of sera from noninfected patients and from experimentally infected rabbits for anti-H and anti-O antibodies; S. marcescens O-antigen cross-reactions with those of other enterobacteriaceae.
    Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):490-6. PubMed ID: 7036590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activity of selected clinical isolates of Serratia marcescens against human serum proteins.
    Doerr M; Traub WH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):196-207. PubMed ID: 6181630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of the commercial human IgG immunoglobulin preparation Polyglobin to enhance combined phagocytic and serum bactericidal activity of normal blood against Serratia marcescens.
    Traub WH
    Chemotherapy; 1983; 29(1):43-7. PubMed ID: 6339179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.
    Griffiss JM
    J Immunol; 1975 Jun; 114(6):1779-84. PubMed ID: 805178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on rabbit hyperimmune, patient and blood donor serum with regard to bactericidal activity and serum antibodies against anaerobic curved rods from patients with bacterial vaginosis.
    Moi H; Danielsson D
    Scand J Urol Nephrol Suppl; 1984; 86():87-91. PubMed ID: 6399411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
    Simberkoff MS; Ricupero I; Rahal JJ
    J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver.
    Fierer J; Finley F
    J Clin Invest; 1979 May; 63(5):912-921. PubMed ID: 376551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
    Clark NM; Berberov EM; Wang M; Moxley RA
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.